Status:
COMPLETED
Comparison of Strategies Based on RT-PCR or Antigenic Test for the Screening of SARS-CoV-2 Infection (COVID-19).
Lead Sponsor:
Centre Hospitalier Universitaire de Saint Etienne
Conditions:
SARS-CoV Infection
Eligibility:
All Genders
10+ years
Phase:
NA
Brief Summary
The virological diagnosis of SARS-CoV-2 infection is pivotal for the control of the outbreak by large screening of a- or pauci-symptomatic subjects. Despite nasopharyngeal swabbing tested by RT-PCR is...
Detailed Description
The main objective is to evaluate the performance of a strategy for screening for CoV-2-SARS infection that would combine 1) a salivary self-sample with an anterior nasal swab and 2) a diagnostic anti...
Eligibility Criteria
Inclusion
- Adult age or at least 10 year old able to perform self-sampling of saliva and anterior nare swabbing
- Subject or legal tutor agreeing to participate to self-sampling and to collect anonymized data required by the present research
Exclusion
- Inability to understand the protocol (language barrier notably)
- Deny to participate to the proposed research
- Patients under tutorship
Key Trial Info
Start Date :
February 22 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 28 2021
Estimated Enrollment :
10000 Patients enrolled
Trial Details
Trial ID
NCT04859023
Start Date
February 22 2021
End Date
February 28 2021
Last Update
May 6 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Saint-Etienne
Saint-Etienne, France